Patrick James Orme

Array ( [id] => 341484 [patent_doc_number] => 07501242 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-10 [patent_title] => 'Detection of colon or breast cancer by measuring TTK polynucleotide expression' [patent_app_type] => utility [patent_app_number] => 10/951389 [patent_app_country] => US [patent_app_date] => 2004-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19774 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/501/07501242.pdf [firstpage_image] =>[orig_patent_app_number] => 10951389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 341486 [patent_doc_number] => 07501244 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-10 [patent_title] => 'Determining prognosis of colon or breast cancer by measuring TTK expression' [patent_app_type] => utility [patent_app_number] => 10/951477 [patent_app_country] => US [patent_app_date] => 2004-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19782 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/501/07501244.pdf [firstpage_image] =>[orig_patent_app_number] => 10951477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 341485 [patent_doc_number] => 07501243 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-10 [patent_title] => 'Detection of colon or breast cancer by measuring TTK polypeptide expression' [patent_app_type] => utility [patent_app_number] => 10/951406 [patent_app_country] => US [patent_app_date] => 2004-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19779 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/501/07501243.pdf [firstpage_image] =>[orig_patent_app_number] => 10951406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5349378 [patent_doc_number] => 20090004739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'Efficient Method of Preparing Dna Inverted Repeat' [patent_app_type] => utility [patent_app_number] => 10/572750 [patent_app_country] => US [patent_app_date] => 2004-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 5630 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004739.pdf [firstpage_image] =>[orig_patent_app_number] => 10572750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7195877 [patent_doc_number] => 20050164235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Modified iRNA agents' [patent_app_type] => utility [patent_app_number] => 10/946873 [patent_app_country] => US [patent_app_date] => 2004-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 45982 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164235.pdf [firstpage_image] =>[orig_patent_app_number] => 10946873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5155000 [patent_doc_number] => 20070037883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Therapeutic compositions' [patent_app_type] => utility [patent_app_number] => 10/547613 [patent_app_country] => US [patent_app_date] => 2004-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 32723 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037883.pdf [firstpage_image] =>[orig_patent_app_number] => 10547613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7074334 [patent_doc_number] => 20050147602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Compositions, methods and kits relating to CTHRC1, a novel modulator of collagen matrix' [patent_app_type] => utility [patent_app_number] => 10/939233 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 65437 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 49 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20050147602.pdf [firstpage_image] =>[orig_patent_app_number] => 10939233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427655 [patent_doc_number] => 08703728 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini' [patent_app_type] => utility [patent_app_number] => 10/935958 [patent_app_country] => US [patent_app_date] => 2004-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 33848 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10935958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7252137 [patent_doc_number] => 20050074801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry' [patent_app_type] => utility [patent_app_number] => 10/936273 [patent_app_country] => US [patent_app_date] => 2004-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 66399 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20050074801.pdf [firstpage_image] =>[orig_patent_app_number] => 10936273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7145431 [patent_doc_number] => 20050119214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Nuclease resistant double-stranded ribonucleic acid' [patent_app_type] => utility [patent_app_number] => 10/936115 [patent_app_country] => US [patent_app_date] => 2004-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 39065 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119214.pdf [firstpage_image] =>[orig_patent_app_number] => 10936115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5005513 [patent_doc_number] => 20070203084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Interfering Rna Duplex Having Blunt-Ends And 3\'-Modifications' [patent_app_type] => utility [patent_app_number] => 10/569927 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6265 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203084.pdf [firstpage_image] =>[orig_patent_app_number] => 10569927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4983425 [patent_doc_number] => 20070087984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'Method of identifying agents that inhibit the growth of cancer cells' [patent_app_type] => utility [patent_app_number] => 10/570911 [patent_app_country] => US [patent_app_date] => 2004-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 22115 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20070087984.pdf [firstpage_image] =>[orig_patent_app_number] => 10570911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7103868 [patent_doc_number] => 20050106594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'In vitro selection of aptamer beacons' [patent_app_type] => utility [patent_app_number] => 10/924144 [patent_app_country] => US [patent_app_date] => 2004-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 19103 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106594.pdf [firstpage_image] =>[orig_patent_app_number] => 10924144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 228883 [patent_doc_number] => 07601696 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-10-13 [patent_title] => 'Oct-1 as an oncoprotein and use of nucleic acid inhibitors of Oct-1 for cancer treatment' [patent_app_type] => utility [patent_app_number] => 10/711101 [patent_app_country] => US [patent_app_date] => 2004-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3190 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/601/07601696.pdf [firstpage_image] =>[orig_patent_app_number] => 10711101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 82265 [patent_doc_number] => 07745608 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Modified iRNA agents' [patent_app_type] => utility [patent_app_number] => 10/916185 [patent_app_country] => US [patent_app_date] => 2004-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 27 [patent_no_of_words] => 129679 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745608.pdf [firstpage_image] =>[orig_patent_app_number] => 10916185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7224075 [patent_doc_number] => 20050261218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Oligomeric compounds and compositions for use in modulation small non-coding RNAs' [patent_app_type] => utility [patent_app_number] => 10/909125 [patent_app_country] => US [patent_app_date] => 2004-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 144662 [patent_no_of_claims] => 110 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261218.pdf [firstpage_image] =>[orig_patent_app_number] => 10909125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6971739 [patent_doc_number] => 20050037449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Agent for controlling circadian rhythm disorder' [patent_app_type] => utility [patent_app_number] => 10/901923 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10287 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037449.pdf [firstpage_image] =>[orig_patent_app_number] => 10901923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7330717 [patent_doc_number] => 20040254359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Antisense modulation of stearoyl-coa desaturase expression' [patent_app_type] => new [patent_app_number] => 10/484442 [patent_app_country] => US [patent_app_date] => 2004-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25870 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254359.pdf [firstpage_image] =>[orig_patent_app_number] => 10484442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 307583 [patent_doc_number] => 07531649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-12 [patent_title] => 'Aptamers to human epidermal growth factor receptor-3' [patent_app_type] => utility [patent_app_number] => 10/563888 [patent_app_country] => US [patent_app_date] => 2004-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14394 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/531/07531649.pdf [firstpage_image] =>[orig_patent_app_number] => 10563888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6938537 [patent_doc_number] => 20050112100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Sp1 and Sp3 targeted cancer therapies and therapeutics' [patent_app_type] => utility [patent_app_number] => 10/888875 [patent_app_country] => US [patent_app_date] => 2004-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 46763 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112100.pdf [firstpage_image] =>[orig_patent_app_number] => 10888875 [rel_patent_id] =>[rel_patent_doc_number] =>)